Company page
Alnylam Pharmaceuticals, Inc.
Alnylam Pharmaceuticals, Inc. is a public company traded under the ticker ALNY in the American market. The company has a market capitalization of approximately $36.3 billion. Alnylam focuses on developing innovative therapies based on RNA interference to treat genetic diseases.
- Ticker
- ALNY:NASDAQ
- Asset type
- Stock
- Market cap
- $31.73B
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- NASDAQ
- Currency
- USD